1Fisher B,Jeong JH,Anderson S,et al.Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation[].New England Journal of Medicine The.2002
2Bonadonna G,Valagussa P,Moliterni A,et al.Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up[].New England Journal of Medicine The.1995
3Mamounas EP,Bryant J,Lembersky B,et al.Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28[].Journal of Clinical Oncology.2005
4Fisher B,Brown A,Mamounas E,et al.Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18[].Journal of Clinical Oncology.1997
5Howell A,Cuzick J,Baum M,et al.Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer[].LancetThe.2005
6Fisher B,Anderson S,Redmond CK,et al.Reanal y sis and results after 12 y ears of follow-up in a randomized clinical trial comp arin g total mastectomy with lump ectomy with or without irradiation in the treatment of breast cancer[].The New England Journal of Medicine.1995
7BonadonnaG,MoliterniA,ZambettiM,etal.30yearsYfollowupofrandomizedstudiesofadjuvantCMFinoperablebreastcancer:cohortstudy[].British Medical Journal.2005
8Henderson IC,Berry DA,Demetri GD,et al.Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer[].Journal of Clinical Oncology.2003
9Fisher,B,Redmond,C,Brown,A.Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: five year results from the NSABP trial[].Journal of Clinical Oncology.1986
10Coates AS,Keshaviah A,Thurlimann B,et al.Five years ofletrozole compared with tamoxifen as initial adjuvant therapy forpostmenopausal women with endocrine-responsive early breastcancer:update of study BIG 1-98[].Journal of Clinical Oncology.2007
5Weigelt B,Peterse J L.,van T V L.Breast cancer metastasis : markers and models[J].Nat Rev Cancer,2005,5 ( 8 ) : 591-602.
6Masueei G L, Donath D, Tetreauh-Laflamme A, et al. Comparison between high and low source activity seeds for I-125 pemanent seed prostate brachytherapy[J].Int J Hadiat Oncol Biol Phys,2010,78 ( 3 ) : 781-786.
